Nippon Jibiinkoka Gakkai Kaiho
Online ISSN : 1883-0854
Print ISSN : 0030-6622
ISSN-L : 0030-6622
Search
Advanced search
OR
Browse
Search
Volume 112, Issue 7
Displaying 1-5 of 5 articles from this issue
Show all abstracts
    • |<
    • <
    • 1
    • >
    • >|
Review article
Original article
  • Clinical Features of Elderly Outpatients
    Saiko Sugiura, Yasue Uchida, Tsutomu Nakashima
    2009 Volume 112 Issue 7 Pages 534-539
    Published: 2009
    Released on J-STAGE: October 26, 2010
    DOIhttps://doi.org/10.3950/jibiinkoka.112.534
    JOURNAL FREE ACCESS
    Show abstractHide abstract
    With Japan facing a rapidly aging society and health care for the latter-stage elderly only set up in April 2008, we analyzed the clinical features of elderly otolaryngology outpatients to clarify any differences between early and latter-stage elderly. Subjects were 627 men and 702 women divided by age into below middle age (under 41 years old), middle-aged (41 to 64 years old), early-stage elderly (65 to 74 years old), and latter-stage elderly (over 74 years old). The most common symptom was sore throat in those below middle age, vertigo in those middle-aged on early-stage elderly, and hearing disorder in those latter-stage elderly. Older subjects took more medication, had more health problems, waited longer before going to an outpatient treatment facility, and visited such facilities less voluntarily. Central vertigo increased in the elderly, seen in 26% of the latter-stage elderly. Those whose chief symptom involved hearing doubled among the latter-stage elderly, 70% of whom had moderate to severe hearing problems. It is therefore imperative to understand the clinical background of elderly patients and to concentrate on learning about and treating vertigo and hearing problems.
    View full abstract
    Download PDF (689K)
  • Clinical Review of Supracricoid Laryngectomy with CHEP and CHP: 50 Patients Treated in 11 Years
    Meijin Nakayama, Yutomo Seino, Seiichi Hayashi, Shunsuke Miyamoto, Mas ...
    2009 Volume 112 Issue 7 Pages 540-549
    Published: 2009
    Released on J-STAGE: October 26, 2010
    DOIhttps://doi.org/10.3950/jibiinkoka.112.540
    JOURNAL FREE ACCESS
    Show abstractHide abstract
    An analysis of clinical data on 50 patients undergoing supracricoid laryngectomy (SCL) between 1997 and 2008 i.e., cricohyoidoepiglottopexy (CHEP) in 47 and cricohyoidopexy (CHP) in 3 cases showed that the number of SCL cases operated on within a year surpassed that of Total Laryngectomy after 2003. Selection criteria included performance status 0-1 and blood gas PO2>80 torr, especially in those patients over 70 years old. Postoperative wound infection occurred in 16 patients (32%), with four requiring additional surgical intervention (two ruptured pexis and two chondritis induced by C3-C4 osteophytes). A history of radiotherapy and systemic complications, i.e., diabetes and renal failure, added to the risk of wound infection. Introducing a clinical pathway shortened hospitalization. Vocal function was achieved in 96% and swallowing function in 89% of patients. Five-year crude survival in CHEP was 69% and in TL 51%. Laryngeal preservation was 70%, increasing to 89% after the introduction of SCL. SCL-CHEP is thus indicated for unfavorable T2 (ASCO 2006), well-selected T3, T4, and rT1-4 (radiation failures). Effort should emphasize a good balance in prognosis and function in organ preservation for laryngeal cancer.
    View full abstract
    Download PDF (810K)
  • Mohs' Ointment Use in Controlling Advanced Head and Neck Cancer
    Kazuhiko Minami, Naoko Hasegawa, Osamu Fukuoka, Chie Miyajima, Reiko T ...
    2009 Volume 112 Issue 7 Pages 550-553
    Published: 2009
    Released on J-STAGE: October 26, 2010
    DOIhttps://doi.org/10.3950/jibiinkoka.112.550
    JOURNAL FREE ACCESS
    Show abstractHide abstract
    Mohs' chemosurgery, originally developed to treat skin cancer, uses zinc chloride in Mohs' ointment to fix tissues, and is applicable in different clinical settings.
    In advanced head and neck cancer, Mohs' chemosurgery relieves main skin-infiltration symptoms such as bleeding, infection, exudation, and severe pain. Mohs' chemosurgery conducted in two cases of advanced head and neck cancer yielded an acceptable result free of bleeding, pain, exudation, and infection.
    Steps in palliative care are repeated until the tumor surface is completely fixed. Using Mohs' ointment provides acceptable relief without technical complications. Although not a topical chemotherapeutic agent, it fixes the lesion well.
    View full abstract
    Download PDF (1630K)
Educational lecture
    • |<
    • <
    • 1
    • >
    • >|
feedback
 Top